Aguirre, Nelibeth B.
HRN: 06 41 47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/17/2023
05/24/2023
IV
600 Mg
Q8hrs
Avulsed Wound; Transected Tendon
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes